Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO(TM)

SAN DIEGO, May 20, 2016 -- (Healthcare Sales & Marketing Network) -- Otonomy, Inc. (OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that t... Biopharmaceuticals, ReimbursementOtonomy, OTIPRIO, ciprofloxacin otic
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news